Catalyst Wire Dossier Catalyst Wire Dossier

Zebutinib

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Zebutinib, covering 2021-07-28 to 2025-09-30. Get the full timeline:

Most recent: Clinical Trial Update: Exploratory Study on the Efficacy of Zebutinib as Maintenance Therapy Following CAR-T Cell Therapy in Patients With Non-Hodgkin B-Cell Lymphoma

See pricing